Karnani Vikram Insider Trades

Insider Trading History

Track insider trading activity for Karnani Vikram. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
President And CEO
Holding Value $6.5M 209,160 shares
Last Trade
Feb 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.23M 111,795 shares
$46.75
$31.06
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
President And CEO
Holding Value $6.15M 197,864 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$528k 11,296 shares
$46.75
$31.06
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $1.07M 59,665 shares
Last Trade
Dec 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 59,665 shares
$20.78
$17.99
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
President And CEO
Holding Value $3.01M 96,989 shares
Last Trade
Nov 12, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$425k 8,983 shares
$47.35
$31.06
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
President And CEO
Holding Value $4.05M 130,344 shares
Last Trade
Nov 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.09M 130,344 shares
$31.41
$31.06
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $12.2M 104,810 shares
Last Trade
Feb 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$729k 8,358 shares
$87.19
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $13.2M 113,394 shares
Last Trade
Feb 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 20,408 shares
$87.17
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $13.1M 112,523 shares
Last Trade
Feb 17, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.9k 871 shares
$87.17
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $13M 111,429 shares
Last Trade
Jan 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$210k 2,731 shares
$76.81
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $13.5M 116,333 shares
Last Trade
Jan 21, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$380k 4,904 shares
$77.43
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $570k 4,905 shares
Last Trade
Jan 21, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$380k 4,904 shares
$77.43
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $13.3M 114,160 shares
Last Trade
Jan 21, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$168k 2,173 shares
$77.43
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $13M 111,429 shares
Last Trade
Jan 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.25M 30,031 shares
$75.00
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $16.5M 141,460 shares
Last Trade
Jan 05, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.66M 49,906 shares
$73.28
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $14.7M 126,278 shares
Last Trade
Jan 05, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.47M 47,337 shares
$73.28
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $22.3M 191,366 shares
Last Trade
Jan 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.77M 65,088 shares
$73.28
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $2.81M 24,190 shares
Last Trade
Jan 05, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.47M 47,337 shares
$73.28
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $2.44M 20,957 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.52M 20,957 shares
$72.54
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $8.47M 72,828 shares
Last Trade
Aug 03, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.32M 36,772 shares
$63.07
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & President, International
Holding Value $9.18M 78,941 shares
Last Trade
Aug 03, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.32M 36,772 shares
$63.07
$116.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up